MALIN CORP PLC (MLC.I) Stock Price, Quote, News and Overview
DUB:MLC - Euronext Dublin - IE00BVGC3741 - Common Stock - Currency: EUR
MLC.I Quote, Performance and Key Statistics
DUB:MLC (3/6/2025, 7:00:00 PM)
9.9
0 (0%)
The current stock price of MLC.I is 9.9 EUR. In the past month the price increased by 13.79%. In the past year, price increased by 115.22%.
MLC.I Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TN8.DE | THERMO FISHER SCIENTIFIC INC | 24.07 | 182.78B | ||
| DAP.DE | DANAHER CORP | 28.32 | 139.67B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 55.77 | 19.00B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 55.17 | 18.79B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 46.36 | 17.15B | ||
| SRT.DE | SARTORIUS AG | 37.17 | 13.75B | ||
| ILU.DE | ILLUMINA INC | 34.19 | 12.24B | ||
| ESF0.DE | EUROFINS SCIENTIFIC | 28.63 | 9.95B | ||
| ERF.PA | EUROFINS SCIENTIFIC | 28.53 | 9.91B | ||
| QIA.DE | QIAGEN N.V. | 18.07 | 7.89B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 25.09 | 3.74B | ||
| GXI.DE | GERRESHEIMER AG | 25.2 | 2.77B |
Related stock screener links
About MLC.I
Company Profile
Malin Corp. Plc.invests and supports innovative life sciences companies, which develops exceptional science and technology to deliver transformative outcomes for patients. The company is headquartered in Dublin, Dublin and currently employs 3 full-time employees. The company went IPO on 2015-03-25. The Company’s assets give investors access to life sciences businesses with exposure across diverse modalities, therapeutic areas and geographies. Its business includes Poseida, Viamet, Xenex, CG Oncology, Wren, KNOW Bio and Artizan. Poseida is a clinical-stage biopharmaceutical company building a pipeline of Chimeric antigen receptor T cell (CAR-T) product candidates, initially focused on the treatment of hematological malignancies, including multiple myeloma, and solid tumours, like prostate cancer. The company is also developing two CAR-T therapies: autologous and allogeneic. Xenex is a commercial-stage medical device company focused on reducing healthcare-associated infections with its non-mercury, full-spectrum disinfection LightStrike Germ-Zapping robots. CG Oncology is an oncolytic immunotherapy company that is intensely focused on developing bladder-saving therapeutics for patients with bladder cancer.
Company Info
MALIN CORP PLC
The Lennox Building, 50 Richmond Street South
DUBLIN DUBLIN IE
Employees: 3
Company Website: http://malinplc.com/
Investor Relations: http://malinplc.com/investors/investor-centre/
Phone: 35319015700
MALIN CORP PLC / MLC.I FAQ
What is the stock price of MALIN CORP PLC today?
The current stock price of MLC.I is 9.9 EUR.
What is the ticker symbol for MALIN CORP PLC stock?
The exchange symbol of MALIN CORP PLC is MLC and it is listed on the Euronext Dublin exchange.
On which exchange is MLC.I stock listed?
MLC.I stock is listed on the Euronext Dublin exchange.
What is the price forecast or stock price prediction for MALIN CORP PLC stock?
5 analysts have analysed MLC.I and the average price target is 15.81 EUR. This implies a price increase of 59.7% is expected in the next year compared to the current price of 9.9. Check the MALIN CORP PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MALIN CORP PLC worth?
MALIN CORP PLC (MLC.I) has a market capitalization of 187.01M EUR. This makes MLC.I a Micro Cap stock.
How many employees does MALIN CORP PLC have?
MALIN CORP PLC (MLC.I) currently has 3 employees.
What are the support and resistance levels for MALIN CORP PLC (MLC.I) stock?
MALIN CORP PLC (MLC.I) has a support level at 8.69 and a resistance level at 9.97. Check the full technical report for a detailed analysis of MLC.I support and resistance levels.
Should I buy MALIN CORP PLC (MLC.I) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MLC.I, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MLC.I, evaluating the profitability, health, valuation and growth aspects
- MALIN CORP PLC (MLC.I) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MALIN CORP PLC (MLC.I) Sales and EPS estimates to see what analysts future expectations are.
- MALIN CORP PLC (MLC.I) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MALIN CORP PLC (MLC.I) Insider and Institutional Ownership to learn about the owners and their transactions.
- MALIN CORP PLC (MLC.I) Stock Chart to make your own analysis
- MALIN CORP PLC (MLC.I) Latest news and press-releases to stay up to date.
Does MALIN CORP PLC (MLC.I) stock pay dividends?
MLC.I does not pay a dividend.
When does MALIN CORP PLC (MLC.I) report earnings?
MALIN CORP PLC (MLC.I) will report earnings on 2025-08-25.
MLC.I Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to MLC.I. When comparing the yearly performance of all stocks, MLC.I is one of the better performing stocks in the market, outperforming 96.94% of all stocks.
MLC.I Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MLC.I Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to MLC.I. The Buy consensus is the average rating of analysts ratings from 5 analysts.